{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"condition":["Rectal Neoplasms","Colon Cancer","Colorectal cancer","Rectal Cancer","Colonic Neoplasms"],"disease":["Rectal Neoplasms","Colon Cancer","Colorectal Cancer","Rectal Cancer","Colonic Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2107443"],"location":["United States"],"study_start_month":["5"],"keyword":["Chemo/radiation","Oxaliplatin","Neoadjuvant","Leucovorin","Rectum cancer"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)","description":"The purpose of this study is to find out how well patients with cancer of the rectum do if they get all of their other treatment - chemotherapy by itself followed by chemotherapy and radiation together - before surgery. Patients have recently been diagnosed with rectal cancer, and the doctors have recommended neo-adjuvant chemo treatment to try to shrink the cancer before removing it.","dates":{"creation":"2010-05-15"},"accession":"2107443","cross_references":{"ClinicalTrials___gov":["NCT01363843"]}}